.... Prostate carcinoma Internet Guidelines Accordance Information behavior Information seeking An increasing number of patients are screening the internet for information on their disease [ 1 ]. As PCa displays the second most common malignancy worldwide, it seems logical that PCa is one...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Antimicrobial resistance Infection Prostate biopsy Prostate cancer Prostate carcinoma Transrectal ultrasonography...

...K. Gyftopoulos; K. Vourda; G. Sakellaropoulos; P. Perimenis; A. Athanasopoulos; E. Papadaki Objective: Angiogenesis is essential for tumor growth and metastasis; however, angiogenic factors are not uniformly expressed in prostate carcinoma. Our aim was to determine the expression of vascular...

... sonography Benign prostatic hyperplasia Prostate carcinoma Abstract Digital rectal examination, prostate-specific antigen and transrectal sonography (TRS) are the main diagnostic tools for evaluating men at risk for carcinoma of the prostate (PCa). PCa has a hypoechoic echo pattern via TRS in 6085% of cases...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. p53 Tumor suppressor gene Immunohistochemistry Prostate carcinoma 30 05 1996 16 01 1997 4 2 2010...

... monoclonal antibody Prostate carcinoma Glycolipid Original Paper Urol Int 1992;48:20-24 Makoto Satoha Yasuo Fukushib Sadafwni Kawamuraa Chikara Ohyamaa Seiichi Saitoa Seiichi Orikasaa Edward Nudlemanc Sen-itiroh Hakamoric Glycolipid Expression in Prostatic Tissue and Analysis of the Antigen Recognized...

... are described with a brief review of the relevant literature. Prostate Prostate carcinoma Prostate neoplasm © 1994 S. Karger AG, Basel 1994 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Malignant priapism Prostate carcinoma Diagnostics 7 06 1993 7 07 1993 3 2 2010 Case Report Urol Int 1994;52:52-54 I. Schroeder-Printzena R...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Cancer genetics Tumor suppressor genes RB gene p53gene Tumour progression Prognosis Bladder carcinoma Prostate carcinoma Urological tumours Original Paper Urol Int 1994;53:1-5 J.M. W olff...

... subjective improvement for 2 months. However, during the 3rd month of treatment there was global deterioration which progressed further till his demise during the 4th month. The beneficial role, if any, of combined hormonal and immunotherapy in advanced prostatic carcinoma is discussed as also the natural...

... to in the content or advertisements. Prostate carcinoma Stage T 0b , T 1 + T 2 , T 3 Nonradical prostatectomy Urol. int. 42: 49-52 (1987) >1987 S. Kargcr AG, Basel 0042-1138/87/0421-0049S2.75/0 Cancer of the Prostate: Is There a Need for Aggressive Treatment? Boaz Moskovitz, Sami Nitecki, Dan Richter...

...Boaz Moskovitz; Hedviga Kerner; Dan Richter Levin In 1 out of 56 patients, orchiectomized in the course of treatment for prostatic carcinoma, metastatic growth in the testis was found. This uncommon metastatic spread is a sign of advanced disease. 30 09 1986 14 10 1986 2 2 2010...

... to attain further improvement of the actuarial survival in metastatic prostate carcinoma. 23 04 1987 29 04 1987 2 2 2010 Prostate carcinoma Specific immunotherapy © 1987 S. Karger AG, Basel 1987 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...

... increase in the survival rate during treatment of unconfined metastasizing prostate carcinomas. Even in early stages specific immunotherapy constitutes a new alternative therapeutic method, particularly in the treatment of hormone-independent prostate carcinomas and in cases of estrogen intolerance. 23...

... in prostatic carcinoma, chemotherapy can be of some usefulness in urology, either alone or in addition to surgery and radiotherapy. The experience is still limited, due to the fact that chemotherapy is not a specific treatment against cancer but, by a generalized cytotoxicity on cells in the reproductive cycle...

... Prostate carcinoma Serum ghrelin Serum obestatin Urologia Internationalis Original Paper Urol Int 2009;83:471 475 DOI: 10.1159/000251190 Received: May 15, 2008 Accepted after revision: January 13, 2009 Elevated Blood Active Ghrelin and Unaltered Total Ghrelin and Obestatin Concentrations in Prostate...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostate carcinoma Transitional...

.... The bcl 2 expression was a characteristic of the tumors of patients who later died. These results show that the degree of induction of apoptosis in prostate carcinoma by hormonal therapy varies from case to case. A given prostate cancer patient’s response to therapy may be predicted by following apoptotic...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostate carcinoma Prostate-specific antigen Malignant pleural effusion 5 6 1998 Gordon A. Brown Phillip C. Ginsberg Richard C. Harkaway Albert Einstein Medical Center...